LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 332 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $425,432 | -16.9% | 7,100 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $511,910 | +34.0% | 7,100 | +183.4% | 0.00% | – |
Q1 2021 | $382,000 | -92.8% | 2,505 | -93.6% | 0.00% | -100.0% |
Q4 2018 | $5,327,000 | +6.1% | 39,256 | +114.7% | 0.01% | +20.0% |
Q3 2018 | $5,019,000 | +56.0% | 18,285 | +17.8% | 0.01% | +66.7% |
Q2 2018 | $3,217,000 | -29.7% | 15,527 | -43.9% | 0.00% | -25.0% |
Q1 2018 | $4,575,000 | -13.2% | 27,702 | -28.0% | 0.00% | 0.0% |
Q4 2017 | $5,270,000 | -30.0% | 38,488 | -30.4% | 0.00% | -42.9% |
Q3 2017 | $7,531,000 | -9.4% | 55,317 | -19.2% | 0.01% | -12.5% |
Q2 2017 | $8,310,000 | +22.3% | 68,450 | +6.6% | 0.01% | +14.3% |
Q1 2017 | $6,796,000 | -14.0% | 64,214 | -17.4% | 0.01% | 0.0% |
Q4 2016 | $7,900,000 | -40.6% | 77,741 | -40.3% | 0.01% | -46.2% |
Q3 2016 | $13,290,000 | -12.9% | 130,218 | +1.7% | 0.01% | -18.8% |
Q2 2016 | $15,265,000 | -45.2% | 127,991 | -50.8% | 0.02% | -50.0% |
Q1 2016 | $27,845,000 | +1.6% | 260,016 | +2.9% | 0.03% | +3.2% |
Q4 2015 | $27,401,000 | +45.4% | 252,731 | +14.8% | 0.03% | +40.9% |
Q3 2015 | $18,848,000 | -29.4% | 220,060 | -16.8% | 0.02% | -24.1% |
Q2 2015 | $26,684,000 | -3.6% | 264,459 | -26.3% | 0.03% | -9.4% |
Q1 2015 | $27,678,000 | +26.9% | 358,938 | -12.4% | 0.03% | +33.3% |
Q4 2014 | $21,805,000 | +16.9% | 409,781 | +2.7% | 0.02% | +9.1% |
Q3 2014 | $18,648,000 | +7.7% | 399,083 | +43.6% | 0.02% | 0.0% |
Q2 2014 | $17,314,000 | -7.3% | 277,963 | -0.7% | 0.02% | 0.0% |
Q1 2014 | $18,684,000 | +47.6% | 279,831 | +16.2% | 0.02% | +37.5% |
Q4 2013 | $12,662,000 | +64.5% | 240,722 | +35.4% | 0.02% | +60.0% |
Q3 2013 | $7,695,000 | +21.0% | 177,806 | +4.5% | 0.01% | +11.1% |
Q2 2013 | $6,361,000 | – | 170,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |